Health Care Up on Deal Activity -- Health Care Roundup

FeaturesDow Jones Newswires

Shares of health-care companies rose on deal activity.

Sanofi agreed to buy Belgian biotech Ablynx for $4.85 billion, the French drugmaker's second acquisition this month after purchasing U.S. hemophilia specialist Bioverativ.

Continue Reading Below

Other large-cap drug makers, including Celgene, have also made acquisitions of midsize drug developers in the latest scramble to bolster drug pipelines.

Rob Curran,

(END) Dow Jones Newswires

January 29, 2018 17:39 ET (22:39 GMT)